The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization

Scandinavian Journal of Immunology

Volumn 63, Issue 2, 2006, Pages 97-105

  Akhiani, A A ^a   Stensson, A ^a   Schon K ^a   Lycke, N ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CHOLERA TOXIN; CTA1 DD ADJUVANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BACTERIAL VACCINES; CHOLERA TOXIN; CYTOKINES; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; STATISTICS, NONPARAMETRIC; TH1 CELLS;

EID: 33645065850     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01713.x     Document Type: Article

References (53)

1. Levine MM Can needle-free administration of vaccines become the norm in global immunization? Nat Med 2003 9 99 103
2. Eriksson K Holmgren J Recent advances in mucosal vaccines and adjuvants Curr Opin Immunol 2002 14 666 72
3. Rappuoli R Pizza M Douce G Dougan G Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins Immunol Today 1999 20 493 500
4. Gluck R Mischler R Durrer P et al. Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant J Infect Dis 2000 181 1129 32
5. Blaser MJ Helicobacter pylori and the pathogenesis of gastroduodenal inflammation J Infect Dis 1990 161 626 33
6. Nomura A Stemmermann GN Chyou PH Kato I Perez-Perez GI Blaser MJ Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii N Engl J Med 1991 325 1132 6
7. Parsonnet J Hansen S Rodriguez L et al. Helicobacter pylori infection and gastric lymphoma N Engl J Med 1994 330 1267 71
8. Ruggiero P Peppoloni S Rappuoli R Del Giudice G The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? Microbes Infect 2003 5 749 56
9. Chen M Lee A Hazell S Immunisation against gastric Helicobacter infection in a mouse/Helicobacter felis model Lancet 1992 339 1120 1
10. Chen M Lee A Hazell S Hu P Li Y Immunisation against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer? Zentralbl Bakteriol 1993 280 155 65
11. Michetti P Corthesy-Theulaz I Davin C et al. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease Gastroenterology 1994 107 1002 11
12. Pappo J Thomas WD Kabok Z Taylor NS Murphy JC Fox JG Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis Infect Immun 1995 63 1246 52
13. Ermak TH Giannasca PJ Nichols R et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses J Exp Med 1998 188 2277 88
14. Ghiara P Rossi M Marchetti M et al. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection Infect Immun 1997 65 4996 5002
15. Kleanthous H Myers GA Georgakopoulos KM et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection Infect Immun 1998 66 2879 86
16. Lee CK Soike K Hill J et al. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys Vaccine 1999 17 1493 505
17. van Ginkel FW Jackson RJ Yuki Y McGhee JR Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues J Immunol 2000 165 4778 82
18. Mutsch M Zhou W Rhodes P et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland N Engl J Med 2004 350 896 903
19. Michetti P Kreiss C Kotloff KL et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults Gastroenterology 1999 116 804 12
20. Banerjee S Medina-Fatimi A Nichols R et al. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers Gut 2002 51 634 40
21. Losonsky GA Kotloff KL Walker RI B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT (R192G) in H. pylori seronegative individuals Vaccine 2003 21 562 5
22. Douce G Giuliani MM Giannelli V Pizza MG Rappuoli R Dougan G Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli Vaccine 1998 16 1065 73
23. Giuliani MM Del Giudice G Giannelli V et al. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity J Exp Med 1998 187 1123 32
24. Yamamoto S Takeda Y Yamamoto M et al. Mutants in the ADP- ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity J Exp Med 1997 185 1203 10
25. Agren LC Ekman L Lowenadler B Lycke NY Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit J Immunol 1997 158 3936 46
26. Lycke N ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity Ann N Y Acad Sci 2004 1029 193 208
27. Lycke N From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM Cell Microbiol 2004 6 23 32
28. Choi AH McNeal MM Flint JA et al. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant Vaccine 2002 20 1733 40
29. Kitamura D Roes J Kuhn R Rajewsky K A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene Nature 1991 350 423 6
30. Akhiani AA Pappo J Kabok Z et al. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells J Immunol 2002 169 6977 84
31. Eriksson AM Schon KM Lycke NY The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues J Immunol 2004 173 3310 9
32. Magnusson KE Edebo L Influence of cell concentration, temperature, and press performance on flow characteristics and disintegration in the freeze-pressing of Saccharomyces cerevisiae with the X-press Biotechnol Bioeng 1976 18 865 83
33. Pappo J Torrey D Castriotta L Savinainen A Kabok Z Ibraghimov A Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions Infect Immun 1999 67 337 41
34. Guy B Hessler C Fourage S et al. Systemic immunization with urease protects mice against Helicobacter pylori infection Vaccine 1998 16 850 6
35. Akhiani AA Schon K Lycke N Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice J Immunol 2004 173 3348 56
36. Fox JG Perkins S Yan L Shen Z Attardo L Pappo J Local immune response in Helicobacter pylori-infected cats and identification of H. pylori in saliva, gastric fluid and faeces Immunology 1996 88 400 6
37. Leo O Foo M Sachs DH Samelson LE Bluestone JA Identification of a monoclonal antibody specific for a murine T3 polypeptide Proc Natl Acad Sci USA 1987 84 1374 8
38. Agren L Sverremark E Ekman L et al. The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic Bcl-2- and germinal center-promoting effects J Immunol 2000 164 6276 86
39. Garhart CA Redline RW Nedrud JG Czinn SJ Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice Infect Immun 2002 70 3529 38
40. Akhiani AA Schon K Franzen LE Pappo J Lycke N Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection J Immunol 2004 172 5024 33
41. Tummala S Keates S Kelly CP Update on the immunologic basis of Helicobacter pylori gastritis Curr Opin Gastroenterol 2004 20 592 7
42. Sommer F Wilken H Faller G Lohoff M Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis Infect Immun 2004 72 1029 35
43. Mohammadi M Nedrud J Redline R Lycke N Czinn SJ Murine CD4 T-cell response to Helicobacter infection. TH1 cells enhance gastritis and TH2 cells reduce bacterial load Gastroenterology 1997 113 1848 57
44. Eaton KA Ringler SS Krakowka S Vaccination of gnotobiotic piglets against Helicobacter pylori J Infect Dis 1998 178 1399 405
45. Shirai Y Wakatsuki Y Kusumoto T et al. Induction and maintenance of immune effector cells in the gastric tissue of mice orally immunized to Helicobacter pylori requires salivary glands Gastroenterology 2000 118 749 59
46. Garhart CA Heinzel FP Czinn SJ Nedrud JG Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent Infect Immun 2003 71 910 21
47. Simmons CP Mastroeni P Fowler R et al. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants J Immunol 1999 163 6502 10
48. Fujihashi K Koga T van Ginkel FW Hagiwara Y McGhee JR A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants Vaccine 2002 20 2431 8
49. Agren LC Ekman L Lowenadler B Nedrud JG Lycke NY Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity J Immunol 1999 162 2432 40
50. Aebischer T Laforsch S Hurwitz R Brombacher F Meyer TF Immunity against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and gender of infected mice Infect Immun 2001 69 556 8
51. Garhart CA Nedrud JG Heinzel FP Sigmund NE Czinn SJ Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4 Infect Immun 2003 71 3628 33
52. Bamias G Martin C Mishina M et al. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation Gastroenterology 2005 128 654 66
53. Mattapallil JJ Dandekar S Canfield DR Solnick JV A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques Gastroenterology 2000 118 307 15